Amit G. Pandya

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Howard Sofen

Health Science Clinical Professor

Olive View-UCLA Medical Center

UNITED STATES

View details

Julien Seneschal

Professor in Dermatology

University of Bordeaux

FRANCE

View details

Dana DiBenedetti

Health Solutions

UNITED STATES

View details

Katherine Kosa

Health Solutions

UNITED STATES

View details

T. Passeron

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amit G. Pandya

Research Interests

Explore related searches

Contact this professor

Articles (16)

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies

Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks

Assessing Participants’ Experiences with Vitiligo from Patient Interviews

Safety and Efficacy of Ruxolitinib Cream for the Treatment of Vitiligo: A Randomised Controlled Trial Secondary Analysis at 3 Years

Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations

Clinician‐reported outcome measures for the assessment of vitiligo: A scoping review

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims

Prevalence of Vitiligo among Children and Adolescents in the United States

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm

Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo

Impact of nonsegmental vitiligo on patients’ health-related quality of life in the United States

Noticeability of vitiligo is in the eye of the beholder

Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA

scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T reg function

Collaborators (5)

Howard Sofen

Julien Seneschal

Dana DiBenedetti

Katherine Kosa

T. Passeron

Make your next move.